Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study
- PMID: 34168439
- PMCID: PMC8216667
- DOI: 10.2147/COPD.S302259
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study
Abstract
Purpose: A considerable proportion of patients with chronic obstructive pulmonary disease (COPD) remain undiagnosed and untreated even though they may have a burden of respiratory symptoms that impact quality of life. The OCEAN study assessed the ability of screening questionnaires to identify individuals with, or at risk of, COPD by comparing questionnaire outcomes with spirometric measures of lung function.
Methods: This observational study included participants ≥40 years of age presenting for their annual health examination at a single medical center in Okinawa, Japan. Participants completed COPD screening questionnaires (CAPTURE and COPD-Q), the Chronic Airways Assessment Test (CAAT), and general demographic and health-related questionnaires. The performance characteristics of CAPTURE and COPD-Q were compared with spirometry-based airflow limitation by calculating the area under the receiver operating characteristic (ROC-AUC) curve.
Results: A total of 2518 participants were included in the study; 79% of whom were <60 years of age (mean 52.0 years). A total of 52 (2.1%) participants had airflow limitation defined as forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) <0.7, and 420 (16.7%) participants were classified as Preserved Ratio Impaired Spirometry (PRISm). Among participants with PRISm, 75 (17.9%) had a CAAT total score ≥10. Airflow limitation and PRISm were more prevalent in current smokers versus past smokers. For the CAPTURE questionnaire, ROC-AUC for screening airflow limitation, PRISm, and PRISm with a CAAT total score ≥10 were 0.59, 0.55, and 0.69, respectively; for COPD-Q, these three clinical features were 0.67, 0.58 and 0.68, respectively.
Conclusion: This study demonstrated that CAPTURE and COPD-Q appear to be effective screening tools for identifying symptomatic individuals with undiagnosed, or at risk of developing COPD in adults ≥40 years of age in Okinawa. Furthermore, early diagnosis and management of PRISm is important to improve future outcomes and the societal burden of disease.
Keywords: CAAT; CAPTURE; COPD; COPD-Q; Japan; PRISm.
© 2021 Tamaki et al.
Conflict of interest statement
Kentaro Tamaki, Eishin Sakihara, Hiroaki Miyata, and Norimichi Hirahara belong to the association/institution that received funding for this study from GSK. Takeo Ishii, Shoko Akiyama, Toshihiko Kaise, Masayuki Katsumata and Ryosuke Tawara are employees of GSK and hold shares in GSK. Mei Haruya, Oksana Kirichek and Edgar P. Simard are former employees of GSK. Bruce E. Miller and Ruth Tal-Singer are former employees of GSK and hold shares in GSK. Ruth Tal-Singer reports personal fees from Ena Respiratory, Immunomet, Vocalis Health, and Teva. The authors report no other conflicts of interest in this work.
Figures


Comment in
-
Letter to Editor Regarding the OCEAN Study [Letter].Int J Chron Obstruct Pulmon Dis. 2021 Sep 2;16:2501-2502. doi: 10.2147/COPD.S332598. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34511894 Free PMC article. No abstract available.
Similar articles
-
Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.Int J Chron Obstruct Pulmon Dis. 2021 Sep 23;16:2665-2675. doi: 10.2147/COPD.S322041. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34588775 Free PMC article.
-
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128. JAMA. 2023. PMID: 36786790 Free PMC article.
-
A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.Respir Med. 2016 Nov;120:1-9. doi: 10.1016/j.rmed.2016.09.010. Epub 2016 Sep 15. Respir Med. 2016. PMID: 27817804
-
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28919728 Free PMC article. Review.
-
Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.Respir Med. 2019 Sep;156:58-68. doi: 10.1016/j.rmed.2019.08.004. Epub 2019 Aug 9. Respir Med. 2019. PMID: 31437649 Free PMC article. Review.
Cited by
-
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™).Chronic Obstr Pulm Dis. 2025 May 27;12(3):203-206. doi: 10.15326/jcopdf.2025.0614. Chronic Obstr Pulm Dis. 2025. PMID: 40459433 Free PMC article. No abstract available.
-
Letter to Editor Regarding the OCEAN Study [Letter].Int J Chron Obstruct Pulmon Dis. 2021 Sep 2;16:2501-2502. doi: 10.2147/COPD.S332598. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34511894 Free PMC article. No abstract available.
-
Associated Factors and Pulmonary Function Outcomes of Preserved Ratio Impaired Spirometry: A Scoping Review.Int J Chron Obstruct Pulmon Dis. 2025 Mar 24;20:767-784. doi: 10.2147/COPD.S506115. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40161397 Free PMC article.
-
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6. Respir Res. 2023. PMID: 37031164 Free PMC article.
-
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients.Int J Mol Sci. 2025 May 9;26(10):4526. doi: 10.3390/ijms26104526. Int J Mol Sci. 2025. PMID: 40429672 Free PMC article.
References
-
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD. 2021. Available from: https://goldcopd.org/gold-reports/. Accessed May21, 2021.
-
- Collaborators GBDCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X - DOI - PMC - PubMed
-
- World Health Organisation. The top 10 causes of death. 2020. Available from: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of.... Accessed May21, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous